Improving management of cardiovascular medications during hospitalization

改善住院期间心血管药物的管理

• 批准号: 8387039
• 负责人: ANDREW D AUERBACH
• 金额: $ 18.25万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-01-29 至 2014-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8387039
• 关键词: Adrenergic beta-Antagonists; Affect; Angiotensin-Converting Enzyme Inhibitors; Area; Aspirin; Cardiac; Cardiovascular Diseases; Cardiovascular system; Congestive Heart Failure; Coronary Arteriosclerosis; Data; Development; Drops; Faculty; Fostering; Goals; Healthcare; Hospitalists; Hospitalization; Measures; Mentors; Mentorship; Mid-Career Clinical Scientist Award (K24); Mission; Morbidity - disease rate; National Heart, Lung, and Blood Institute; Operative Surgical Procedures; Outcome; Patient Care; Patients; Pharmaceutical Preparations; Policies; Quality of Care; Research; Research Personnel; Specialist; Translating; Translations; Work; abstracting; care systems; career; health care quality; improved; interest; patient oriented; patient oriented research; programs; public health relevance; research to practice

DESCRIPTION (provided by applicant): In the 10 years I have been on the UCSF faculty, I have developed an independent program focused on three major areas of interest: 1) Understanding how care systems might be best arranged to improve both quality and outcomes of healthcare, such as how cardiologists or hospitalists might affect outcomes of patients with congestive heart failure; 2) Understanding how improve use of beta-blockers in noncardiac surgery as a way to reduce cardiac morbidity, and 3) Improving our ability to measure the quality of healthcare and implement change effectively. My work has placed a particular emphasis on the management of patients with cardiovascular illness who are undergoing major noncardiac surgery as a paradigm for these questions. Over the 5-year K24 award period, my goals are to further develop my research program and mentor investigators who will be passionate about these same areas, and who will become successful independent investigators. To achieve this 5 year goal, this K24 has 2 specific aims: (1) to perform patient-oriented research aimed at understanding how hospitalization for noncardiac surgery produces gaps in cardiac medications and how these gaps affect patient outcomes. I will use local and national data to understand how often cardiovascular medications (for example, use of aspirin in patients with coronary artery disease, or angiotensin-converting enzyme inhibitors in patients with congestive heart failure) are missed or dropped in noncardiac surgery patients, and how discontinuity in these medications impacts patient outcomes. (2) To create a mentorship program that will foster the development of patient-oriented researchers interested in improving the quality of care for patients with cardiovascular disease. I will mentor fellows and junior faculty, and diversify my mentorship portfolio to include a greater emphasis on the development of cardiovascular specialists, hospitalists, and subspecialists who have an interest in quality-improvement (or, translating evidence into practice) research as their career goal.

描述（由申请人提供）：在 UCSF 教职的 10 年里，我开发了一个独立项目，重点关注三个主要兴趣领域：1）了解如何最好地安排护理系统以提高医疗保健的质量和结果，例如心脏病专家或住院医师如何影响充血性心力衰竭患者的结果； 2) 了解如何在非心脏手术中改善 β 受体阻滞剂的使用，以降低心脏病发病率，以及 3) 提高我们衡量医疗保健质量和有效实施变革的能力。我的工作特别强调对正在接受重大非心脏手术的心血管疾病患者的管理，作为这些问题的范例。在为期 5 年的 K24 奖励期内，我的目标是进一步发展我的研究计划，并指导对这些领域充满热情并成为成功的独立研究人员的研究人员。为了实现这一 5 年目标，K24 有 2 个具体目标：(1) 进行以患者为导向的研究，旨在了解非心脏手术住院如何造成心脏药物的缺口以及这些缺口如何影响患者的治疗结果。我将使用当地和国家数据来了解非心脏手术患者错过或放弃心血管药物（例如，冠状动脉疾病患者使用阿司匹林，或充血性心力衰竭患者使用血管紧张素转换酶抑制剂）的频率，以及这些药物的不连续性如何影响患者的预后。 (2) 创建一个导师计划，促进以患者为中心、有兴趣提高心血管疾病患者护理质量的研究人员的发展。我将指导研究员和初级教师，并使我的指导组合多样化，包括更加重视对质量改进（或将证据转化为实践）研究作为职业目标感兴趣的心血管专家、住院医师和亚专科医生的发展。